1-9 of 9
Kevin Copson
Close
Sort by
Journal Articles

Subunit-Specific Analysis of Cohesin-Mutant Myeloid Malignancies Reveals Distinct Ontogeny and Outcomes

Johann-Christoph Jann, Christopher B. Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S. Winer, Martha Wadleigh, Richard M Stone, Daniel J. DeAngelo, Jacqueline S. Garcia, Torsten Haferlach, Coleman Lindsley, Marlise R. Luskin, Maximilian Stahl, Zuzana Tothova
Journal: Blood
Blood (2023) 142 (Supplement 1): 999.
https://doi.org/10.1182/blood-2023-187519
Published: 2023
Journal Articles

Genetic Predictors of Anthracycline Mediated Cardiomyopathy with Induction Chemotherapy in Acute Myeloid Leukemia (AML)

Maximilian F. Stahl, Gerard Giblin, Yiwen Liu, Daniel J DeAngelo, Richard M. Stone, Eric S. Winer, Martha Wadleigh, Coleman Lindsley, Shai Shimony, Kevin Copson, Anne Charles, Anju Nohria, Marlise R. Luskin
Journal: Blood
Blood (2022) 140 (Supplement 1): 6067–6068.
https://doi.org/10.1182/blood-2022-159193
Published: 2022
Journal Articles

Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 Pandemic

Hari S. Raman, Yael Flamand, Marlise R. Luskin, Daniel J. DeAngelo, Richard M. Stone, Jacqueline S. Garcia, Martha Wadleigh, Anne Charles, Kevin Copson, R. Coleman Lindsley, Jr., Rahul S. Vedula, Eric S. Winer
Journal: Blood
Blood (2021) 138 (Supplement 1): 2291.
https://doi.org/10.1182/blood-2021-149692
Published: 2021
Journal Articles

Antifungal Prophylaxis: Impact on Outcomes of Newly Diagnosed AML Patients Treated with a Hypomethylating Agent and Venetoclax

Evan C. Chen, Yiwen Liu, Eric S. Winer, Marlise R. Luskin, Martha Wadleigh, Andrew A. Lane, Rahul S. Vedula, Coleman Lindsley, Kevin Copson, Anne Charles, Donna S. Neuberg, Nicolas C. Issa, Daniel J. DeAngelo, Richard M. Stone, Jacqueline S. Garcia
Journal: Blood
Blood (2021) 138 (Supplement 1): 4126.
https://doi.org/10.1182/blood-2021-148717
Published: 2021
Journal Articles

Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Jurjen Versluis, Yael Flamand, MS, Erika J. Haydu, MD PhD, Rahul S. Vedula, MD, Anne Charles, BS, Kevin Copson, MA, Ofir Wolach, MD, Pavan Bendapudi, MD, Roger Belizaire, MD PhD, Donna S. Neuberg, ScD, Marlise R Luskin, MDMS, R. Coleman Lindsley, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-137741
Published: 2020
Journal Articles

Distinct Clinical and Genetic Factors Predict Early Versus Late Mortality in AML Patients Undergoing Induction Chemotherapy

J. Erika Haydu, MD PhD, Yael Flamand, Rahul S. Vedula, MD, Jurjen Versluis, Anne Charles, BS, Kevin Copson, MA, Donna S. Neuberg, ScD, R. Coleman Lindsley, MD PhD, Marlise R Luskin, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-138817
Published: 2020
Journal Articles

Bcor Mutations Cooperate with Tet2 Deficiency to Promote RAS Transformation of Mouse Hematopoietic Progenitors

Iman Fares, PhD, Rahul S. Vedula, MD, Shabbir M. Vahanvaty, Christopher S Waters, Marlise R. Luskin, MD, Priti Kumari, M.S., Marie McConkey, PhD, Anne Charles, BS, Kevin Copson, MA, Gregory A. Abel, MDMPH, Richard M. Stone, MD, Benjamin L. Ebert, MDPhD, R. Coleman Lindsley, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 888.
https://doi.org/10.1182/blood-2018-99-120096
Published: 2018
Journal Articles

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Rahul S. Vedula, MD, Marlise R. Luskin, MD, Kevin Copson, MA, Priti Kumari, M.S., Anne Charles, BS, Annette S. Kim, MD PhD, Elizabeth A Morgan, MD, Gregory A. Abel, MD MPH, Richard M. Stone, MD, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1819.
https://doi.org/10.1182/blood-2018-99-118746
Published: 2018
Journal Articles

Spliceosome Mutations Are Associated with Frailty in Older Patients with Myeloid Malignancies

Marlise R. Luskin, MD, Angel M. Cronin, MS, Kevin Copson, MA, Wooram Jung, Martha Wadleigh, MD, Daniel J. DeAngelo, MD, David P. Steensma, MD, Jane Driver, MD MPH, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD PhD, Gregory A. Abel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4276.
https://doi.org/10.1182/blood.V130.Suppl_1.4276.4276
Published: 2017